Neha Krishnamohan - Sep 2, 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Neha Krishnamohan
Stock symbol
ARQT
Transactions as of
Sep 2, 2022
Transactions value $
$0
Form type
4
Date filed
9/6/2022, 07:08 PM
Previous filing
Sep 2, 2022
Next filing
Dec 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +29.5K $0.00 29.5K Sep 2, 2022 Common Stock 29.5K $24.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on each of September 2, 2023, September 2, 2024 and September 2, 2025, subject to Reporting Person's continuous service to the Issuer on each such vesting date.